Constance S Martin

age ~97

from Stockbridge, MA

Get Report

Connected to:

Constance Martin Phones & Addresses

Stockbridge, MA
Glendale, MA
Princeton, NJ

Lawyers & Attorneys

Constance L. Martin, Boston MA - Lawyer

view source

Address:

Neighborhood Assistance Corporation of America
672 W Roxbury Pkwy, Boston, MA 02131
6172506222 (Office)

Licenses:

Massachusetts - Active 2006

Education:

Rutgers University School of Law
Degree - JD - Juris Doctor

Specialties:

Advertising - 34%
Litigation - 33%
Appeals - 33%

Constance Lillian Martin, Boston MA - Lawyer

view source

Address:

Neighborhood Assistance Corporation of America
3607 Washington St, Boston, MA 02130
6172506222 (Office)

Licenses:

New York - Currently registered 2007

Education:

Rutgers University

Constance Martin - Lawyer

view source

ISLN:

1000508992

Admitted:

2013

Isbn (Books And Publications)

Textbook of Endocrine Physiology

view source

Author
Constance R. Martin

ISBN #
0195022955

Endocrine Physiology

view source

Author
Constance R. Martin

ISBN #
0195033590

Dictionary of Endocrinology and Related Biomedical Sciences

view source

Author
Constance R. Martin

ISBN #
0195060334

Textbook of Endocrine Physiology

view source

Author
Constance R. Martin

ISBN #
0683055798

Distant Shores: The Odyssey of Rockwell Kent

view source

Author
Constance Martin

ISBN #
0520227115

Distant Shores: The Odyssey of Rockwell Kent

view source

Author
Constance Martin

ISBN #
0520227123

James Hamilton: Arctic Watercolours

view source

Author
Constance Martin

ISBN #
0919224369

Name / Title

Company / Classification

Phones & Addresses

Constance Martin
Commissioner

St Lawrence County
Police Protection · Executive Office · General Government · Individual/Family Services Executive Office · Urban/Community Development · Indvdlfmly Svcs · Court · Public Finance/Taxation/Monetary Policy

3153792222, 3153792276, 3153792202, 3153862048

Us Patents

Tgf-Beta Inhibitors And Use Thereof
view source
US Patent:

20230050148, Feb 16, 2023
Filed:

Jan 11, 2021
Appl. No.:

17/758524
Inventors:

- Cambridge MA, US
Thomas Schurpf - Cambridge MA, US
Adam Fogel - Cambridge MA, US
Christopher Brueckner - Cambridge MA, US
Alan Buckler - Cambridge MA, US
Constance Martin - Cambridge MA, US
Si Tuen Lee-Hoeflich - Cambridge MA, US
International Classification:

C07K 16/22
C07K 16/28
A61P 35/00
Abstract:

The present disclosure provides TGFβ inhibitor therapy for treating immunosuppressive conditions, such as cancer. Selection of suitable therapy and patients who are likely to benefit from such therapy are also disclosed, as well as methods of treating cancer and methods of predicting and monitoring therapeutic response. Related compositions, methods and therapeutic use are also disclosed.

High-Affinity, Isoform-Selective Tgfß1 Inhibitors And Use Thereof
view source
US Patent:

20210122814, Apr 29, 2021
Filed:

Jul 11, 2019
Appl. No.:

17/258771
Inventors:

- Cambridge MA, US
Allan Capili - Somerville MA, US
Thomas Schurpf - Cambridge MA, US
Constance Martin - Arlington MA, US
Kevin B. Dagbay - Brighton MA, US
Christopher Chapron - Watertown MA, US
Stefan Wawersik - Westborough MA, US
Christopher Littlefield - Marblehead MA, US
Gregory J. Carven - Maynard MA, US
Alan Buckler - Arlington MA, US
Susan Lin - Boston MA, US
Justin W. Jackson - Cambridge MA, US
Caitlin Stein - Lebanon NH, US
Andrew Avery - Lebanon NH, US
Anthony Cooper - White River Junction VT, US
Matthew Salotto - Hanover NH, US
International Classification:

C07K 16/22
A61K 45/06
A61P 35/00
Abstract:

Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.

Lrrc33 Inhibitors And Use Thereof
view source
US Patent:

20200181251, Jun 11, 2020
Filed:

May 9, 2018
Appl. No.:

16/611029
Inventors:

- Cambridge MA, US
Gregory J. Carven - Maynard MA, US
Stefan Wawersik - Westborough MA, US
Thomas Schurpf - Cambridge MA, US
Constance Martin - Arlington MA, US
Abhishek Datta - Boston MA, US
Mark Allen Farmer - North Reading MA, US
International Classification:

C07K 16/22
A61P 35/04
A61P 35/02
Abstract:

Disclosed herein are LRRC33 inhibiting agents and related methods and uses thereof. More specifically, therapeutic agents for inhibiting LRRC33 effects in vivo are provided. Such agents are useful for the treatment of various disorders involving cells expressing LRRC33 or LRRC33-containing complexes on the surface of cells.

Isoform-Selective Tgfb1 Inhibitors And Use Thereof
view source
US Patent:

20200079840, Mar 12, 2020
Filed:

Jul 11, 2019
Appl. No.:

16/509068
Inventors:

- Cambridge MA, US
Allan Capili - Somerville MA, US
Thomas Schurpf - Cambridge MA, US
Constance Martin - Arlington MA, US
Kevin B. Dagbay - Brighton MA, US
Christopher Chapron - Watertown MA, US
Stefan Wawersik - Westborough MA, US
Christopher Littlefield - Marblehead MA, US
Gregory J. Carven - Maynard MA, US
Alan Buckler - Arlington MA, US
Susan Lin - Boston MA, US
Justin W. Jackson - Cambridge MA, US
International Classification:

C07K 16/22
A61P 13/12
A61P 1/16
A61P 35/00
A61K 49/00
A61K 45/06
A61K 39/395
C07K 16/28
Abstract:

Disclosed herein are monoclonal antibodies and antigen-binding fragments thereof capable of selectively inhibiting TGFβ1 with high potency. Related compositions, methods and therapeutic use are also disclosed.

Isoform-Specific, Context-Permissive Tgfb1 Inhibitors And Use Thereof
view source
US Patent:

20190209682, Jul 11, 2019
Filed:

Mar 22, 2019
Appl. No.:

16/361486
Inventors:

- Cambridge MA, US
Abhishek Datta - Boston MA, US
Gregory J. Carven - Maynard MA, US
Constance Martin - Arlington MA, US
Ashish Kalra - Belmont MA, US
Kimberly Long - Boston MA, US
Alan Buckler - Arlington MA, US
International Classification:

A61K 39/395
C07K 16/22
G01N 33/574
A61P 35/04
Abstract:

Disclosed herein are therapeutic use of isoform-specific, context-permissive inhibitors of TGFβ1 in the treatment of disease that involve TGFβ1 dysregulation.

Isoform-Specific, Context-Permissive Tgfb1 Inhibitors And Use Thereof
view source
US Patent:

20180207267, Jul 26, 2018
Filed:

Jan 5, 2018
Appl. No.:

15/863564
Inventors:

- Cambridge MA, US
Abhishek Datta - Boston MA, US
Gregory J. Carven - Maynard MA, US
Constance Martin - Arlington MA, US
Ashish Kalra - Belmont MA, US
Kimberly Long - Boston MA, US
Alan Buckler - Arlington MA, US
International Classification:

A61K 39/395
C07K 16/22
G01N 33/574
A61P 35/04
Abstract:

Disclosed herein are therapeutic use of isoform-specific, context-permissive inhibitors of TGFβ1 in the treatment of disease that involve TGFβ1 dysregulation.

License Records

Constance Martin

License #:

00778-A - Active

Issued Date:

Feb 1, 1989

Expiration Date:

Feb 28, 2017

Type:

Licensed Advanced Social Worker

Resumes

Business Owner

view source

Work:

Ubiquity Reserves
Business Owner

Constance Martin

view source

Constance Martin

view source

Skills:

Data Entry
Customer Service
Powerpoint

Constance Martin

view source

Constance Martin

view source

Constance Martin

view source

Constance Martin

view source

Location:

United States

Medicine Doctors

Constance M. Martin

view source

Specialties:

Pediatric Otolaryngology

Work:

Childrens Hospital Medical Center-Otolaryngology
3333 Burnet Ave Ml2011, Cincinnati, OH 45229
5136364355 (phone), 5136368133 (fax)

Languages:

English

Description:

Ms. Martin works in Cincinnati, OH and specializes in Pediatric Otolaryngology. Ms. Martin is affiliated with Cincinnati Childrens Hospital Medical Center, Good Samaritan Hospital, Shriners Hospitals For Children Cincinnati and UC Medical Center.